XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA), the biotech royalty aggregator, announces it has entered into an agreement to acquire Generation Bio Co. (“Generation Bio”) (NASDAQ: GBIO) for a cash price of $4.2913 per share at the closing of the merger. Generation Bio is a biotechnology company that was historically working to change what’s possible for people living with T cell-driven autoimmune diseases. Generation Bio’s approach leveraged cell-targeted lipid nanoparticles (ctLNP) to selectively deliver small interfering RNA (siRNA) to T cells.
Read the full article: XOMA Royalty Enters into Agreement to Acquire Generation Bio //
Source: https://www.globenewswire.com/news-release/2025/12/15/3205887/0/en/XOMA-Royalty-Enters-into-Agreement-to-Acquire-Generation-Bio.html?_gl=1*r7skrd*_up*MQ..*_ga*MTY5NzExMTA2NS4xNzY1ODY5MzMw*_ga_ERWPGTJ5X8*czE3NjU4NjkzMzAkbzEkZzAkdDE3NjU4NjkzMzAkajYwJGwwJGgw